Uluru Inc. (ULUR)

OTCMKTS: ULUR · Delayed Price · USD
0.175
0.000 (0.00%)
Sep 24, 2021 12:00 AM EDT - Market closed
Market Cap3.52M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out20.13M
EPS (ttm)-0.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.000
Previous Close0.175
Day's Range0.175 - 0.175
52-Week Range0.175 - 0.580
Beta-2.27
Analystsn/a
Price Targetn/a
Earnings Daten/a

About ULUR

ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include ...

IndustryPharmaceuticals
Employees2
Stock ExchangeOTCMKTS
Ticker SymbolULUR
Full Company Profile

Financial Performance

In 2017, Uluru's revenue was $717,157, an increase of 62.05% compared to the previous year's $442,565. Losses were -$1.94 million, -56.52% less than in 2016.

Financial Statements

News

There is no news available yet.